Paul Stead
Head of Business Development
Paul brings over 15 years of business development leadership and transactional experience within the biotech industry and multinational corporations (MNCs). His expertise spans both the buy and sell sides, covering multiple therapeutic areas. He served in senior business development roles at Adaptimmune Therapeutics, Inovio Pharmaceuticals and Nimbus Therapeutics, where he successfully led and closed multiple major and strategic clinical and preclinical stage asset and platform technology transactions. Additionally, he held the position of Senior Director, Worldwide Business Development at GlaxoSmithKline. Paul is a scientist by background earning a BSc, then PhD in Pharmaceutical Sciences from the Universities of Bath and Nottingham, respectively. He also holds an MBA from Lehigh University, Bethlehem, PA.
